McMaster “could and should play a key role in Canada’s biomanufacturing future,” researchers told a federal committee this week.
A universal vaccine would take the guesswork out of planning annual vaccines, and would protect against all flu strains and the occurrence of flu pandemics, says infectious disease expert Matthew Miller.
Canada’s Global Nexus for Pandemics and Biological Threats at McMaster University and the University of Saskatchewan’s Vaccine and Infectious Disease Organization (VIDO) have signed a partnership agreement that brings the two institutions together to accelerate vaccine and drug development, human clinical trials and create new diagnostic tools.
